Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 5091838, 9 pages
http://dx.doi.org/10.1155/2016/5091838
Review Article

Cell-Based Therapy for Silicosis

Laboratory of Cellular and Molecular Physiology, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil

Received 20 November 2015; Accepted 16 February 2016

Academic Editor: Ciprian Tomuleasa

Copyright © 2016 Miquéias Lopes-Pacheco et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. C. Leung, I. T. S. Yu, and W. Chen, “Silicosis,” The Lancet, vol. 379, no. 9830, pp. 2008–2018, 2012. View at Publisher · View at Google Scholar
  2. E. Hnizdo and J. Murray, “Risk of pulmonary tuberculosis relative to silicosis and exposure to silica dust in South African gold miners,” Occupational and Environmental Medicine, vol. 55, no. 7, pp. 496–502, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Hnizdo and V. Vallyathan, “Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence,” Occupational and Environmental Medicine, vol. 60, no. 4, pp. 237–243, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. M. T. Filho and U. D. E. P. Santos, “Silicose,” Jornal Brasileiro de Pneumologia, vol. 32, pp. 41–47, 2006. View at Google Scholar
  5. T. Brown, “Silica exposure, smoking, silicosis and lung cancer-complex interactions,” Occupational Medicine, vol. 59, no. 2, pp. 89–95, 2009. View at Publisher · View at Google Scholar
  6. S. Lo Re, Y. Yakoub, R. Devosse et al., “Uncoupling between inflammatory and fibrotic responses to silica: evidence from MyD88 knockout mice,” PLoS ONE, vol. 9, no. 7, Article ID e99383, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Chen, Y. Liu, H. Wang et al., “Long-term exposure to silica dust and risk of total and cause-specific mortality in Chinese workers: a cohort study,” PLoS Medicine, vol. 9, no. 4, Article ID e1001206, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Holanda, M. A. Holanda, M. P. S. Martins, P. H. Felismino, and V. G. F. Pinheiro, “Silicosis in Brazilian pit diggers: relationship between dust exposure and radiologic findings,” American Journal of Industrial Medicine, vol. 27, no. 3, pp. 367–378, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. A. P. S. Carneiro, S. M. Barreto, A. L. Siqueira, F. Cavariani, and F. Forastiere, “Continued exposure to silica after diagnosis of silicosis in Brazilian gold miners,” American Journal of Industrial Medicine, vol. 49, no. 10, pp. 811–818, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. F. S. N. Ribeiro, E. A. De Camargo, E. Algranti, and V. Wunsch Filho, “Occupational exposure to silica in Brazil in 2001,” Revista Brasileira de Epidemiologia, vol. 11, no. 1, pp. 89–96, 2008. View at Publisher · View at Google Scholar
  11. S. K. Jindal, “Silicosis in India: past and present,” Current Opinion in Pulmonary Medicine, vol. 19, no. 2, pp. 163–168, 2013. View at Publisher · View at Google Scholar
  12. T. Kauppinen, “Occupational exposure to carcinogens in the European Union,” Occupational and Environmental Medicine, vol. 57, no. 1, pp. 10–18, 2000. View at Publisher · View at Google Scholar
  13. K. D. Linch, W. E. Miller, R. B. Althouse, D. W. Groce, and J. M. Hale, “Surveillance of respirable crystalline silica dust using OSHA compliance data (1979–1995),” American Journal of Industrial Medicine, vol. 34, no. 6, pp. 547–558, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Pérez-Alonso, J. A. Córdoba-Doña, J. L. Millares-Lorenzo, E. Figueroa-Murillo, C. García-Vadillo, and J. Romero-Morillo, “Outbreak of silicosis in Spanish quartz conglomerate workers,” International Journal of Occupational and Environmental Health, vol. 20, no. 1, pp. 26–32, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. D. J. Weiss, “Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010–2012,” Annals of the American Thoracic Society, vol. 10, no. 5, pp. S45–S97, 2013. View at Publisher · View at Google Scholar
  16. M. Lopes-Pacheco, T. G. Ventura, H. D. de Oliveira et al., “Infusion of bone marrow mononuclear cells reduces lung fibrosis but not inflammation in the late stages of murine silicosis,” PLoS ONE, vol. 9, no. 10, Article ID e109982, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. L. A. Ortiz, F. Gambelli, C. McBride et al., “Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8407–8411, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Schuller-Levis, R. E. Gordon, C. Wang, S. Y. Park, and E. Park, “Protection of bleomycin-induced fibrosis and inflammation by taurine,” International Immunopharmacology, vol. 9, no. 7-8, pp. 971–977, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. F. F. Cruz, M. A. Antunes, S. C. Abreu et al., “Protective effects of bone marrow mononuclear cell therapy on lung and heart in an elastase-induced emphysema model,” Respiratory Physiology and Neurobiology, vol. 182, no. 1, pp. 26–36, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. R. F. Hamilton Jr., S. A. Thakur, and A. Holian, “Silica binding and toxicity in alveolar macrophages,” Free Radical Biology and Medicine, vol. 44, no. 7, pp. 1246–1258, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Tsuda, F. S. Henry, and J. P. Butler, “Particle transport and deposition: basic physics of particle kinetics,” Comprehensive Physiology, vol. 3, no. 4, pp. 1437–1471, 2013. View at Publisher · View at Google Scholar
  22. V. Castranova, “From coal mine dust to quartz: mechanisms of pulmonary pathogenicity,” Inhalation Toxicology, vol. 12, no. 3, pp. 7–14, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Castranova and V. Vallyathan, “Silicosis and coal workers' pneumoconiosis,” Environmental Health Perspectives, vol. 108, no. 4, pp. 675–684, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Huaux, “New developments in the understanding of immunology in silicosis,” Current Opinion in Allergy and Clinical Immunology, vol. 7, no. 2, pp. 168–173, 2007. View at Publisher · View at Google Scholar
  25. G. N. Joshi and D. A. Knecht, “Silica phagocytosis causes apoptosis and necrosis by different temporal and molecular pathways in alveolar macrophages,” Apoptosis, vol. 18, no. 3, pp. 271–285, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. M. I. Greenberg, J. Waksman, and J. Curtis, “Silicosis: a review,” Disease-a-Month, vol. 53, no. 8, pp. 394–416, 2007. View at Publisher · View at Google Scholar
  27. B. Fubini and A. Hubbard, “Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis,” Free Radical Biology and Medicine, vol. 34, no. 12, pp. 1507–1516, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. J. A. Blackford Jr., J. M. Antonini, V. Castranova, and R. D. Dey, “Intratracheal instillation of silica up-regulates inducible nitric oxide synthase gene expression and increases nitric oxide production in alveolar macrophages and neutrophils,” American Journal of Respiratory Cell and Molecular Biology, vol. 11, no. 4, pp. 426–431, 1994. View at Publisher · View at Google Scholar · View at Scopus
  29. P. C. Zeidler, A. Hubbs, L. Battelli, and V. Castranova, “Role of inducible nitric oxide synthase-derived nitric oxide in silica-induced pulmonary inflammation and fibrosis,” Journal of Toxicology and Environmental Health—Part A, vol. 67, no. 13, pp. 1001–1026, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. D. W. Porter, L. Millecchia, V. A. Robinson et al., “Enhanced nitric oxide and reactive oxygen species production and damage after inhalation of silica,” The American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 283, no. 2, pp. L485–L493, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Ding, F. Chen, X. Shi, B. Yucesoy, B. Mossman, and V. Vallyathan, “Diseases caused by silica: mechanisms of injury and disease development,” International Immunopharmacology, vol. 2, no. 2-3, pp. 173–182, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Ding, X. Shi, Z. Dong et al., “Freshly fractured crystalline silica induces activator protein-1 activation through ERKs and p38 MAPK,” The Journal of Biological Chemistry, vol. 274, no. 43, pp. 30611–30616, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Di Giuseppe, F. Gambelli, G. W. Hoyle et al., “Systemic inhibition of NF-κB activation protects from silicosis,” PLoS ONE, vol. 4, no. 5, Article ID e5689, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. S. R. Satpathy, V. R. Jala, S. R. Bodduluri et al., “Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growth,” Nature Communications, vol. 6, article 7064, 2015. View at Publisher · View at Google Scholar
  35. P. Misson, S. van den Brûle, V. Barbarin, D. Lison, and F. Huaux, “Markers of macrophage differentiation in experimental silicosis,” Journal of Leukocyte Biology, vol. 76, no. 5, pp. 926–932, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Lopes-Pacheco, D. G. Xisto, F. M. Ornellas et al., “Repeated administration of bone marrow-derived cells prevents disease progression in experimental silicosis,” Cellular Physiology and Biochemistry, vol. 32, no. 6, pp. 1681–1694, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Poljakovic, D. W. Porter, L. Millecchia et al., “Cell- and isoform-specific increases in arginase expression in acute silica-induced pulmonary inflammation,” Journal of Toxicology and Environmental Health A, vol. 70, no. 2, pp. 118–127, 2007. View at Publisher · View at Google Scholar
  38. S. Murthy, J. L. Larson-Casey, A. J. Ryan, C. He, L. Kobzik, and A. B. Carter, “Alternative activation of macrophages and pulmonary fibrosis are modulated by scavenger receptor, macrophage receptor with collagenous structure,” The FASEB Journal, vol. 29, no. 8, pp. 3527–3536, 2015. View at Publisher · View at Google Scholar
  39. R. Biswas, R. F. Hamilton, and A. Holian, “Role of lysosomes in silica-induced inflammasome activation and inflammation in absence of MARCO,” Journal of Immunology Research, vol. 2014, Article ID 304180, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. P. M. Peeters, T. N. Perkins, E. F. M. Wouters, B. T. Mossman, and N. L. Reynaert, “Silica induces NLRP3 inflammasome activation in human lung epithelial cells,” Particle and Fibre Toxicology, vol. 10, article 3, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. K. D. Srivastava, W. N. Rom, J. Jagirdar, Y. I. E. Ting-An, T. Gordon, and K.-M. Tchou-Wong, “Crucial role of interleukin-1β and nitric oxide synthase in silica-induced inflammation and apoptosis in mice,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 4, pp. 527–533, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. W. P. Arend and C. Gabay, “Physiologic role of interleukin-1 receptor antagonist,” Arthritis Research, vol. 2, no. 4, pp. 245–248, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Yucesoy, V. Vallyathan, D. P. Landsittel et al., “Polymorphisms of the IL-1 gene complex in coal miners with silicosis,” American Journal of Industrial Medicine, vol. 39, no. 3, pp. 286–291, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Vanhee, P. Gosset, A. Boitelle, B. Wallaert, and A. B. Tonnel, “Cytokines and cytokine network in silicosis and coal workers' pneumoconiosis,” European Respiratory Journal, vol. 8, no. 5, pp. 834–842, 1995. View at Google Scholar · View at Scopus
  45. T. A. Wynn and T. R. Ramalingam, “Mechanisms of fibrosis: therapeutic translation for fibrotic disease,” Nature Medicine, vol. 18, no. 7, pp. 1028–1040, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. V. M. Borges, H. Falcão, J. H. Leite-Júnior et al., “Fas ligand triggers pulmonary silicosis,” Journal of Experimental Medicine, vol. 194, no. 2, pp. 155–164, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. V. M. Borges, M. F. Lopes, H. Falcão et al., “Apoptosis underlies immunopathogenic mechanisms in acute silicosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 27, no. 1, pp. 78–84, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Jagirdar, R. Begin, A. Dufresne, S. Goswami, T. C. Lee, and W. N. Rom, “Transforming growth factor-beta (TGF-beta) in silicosis,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 4, pp. 1076–1081, 1996. View at Publisher · View at Google Scholar
  49. T. J. Mariani, E. Crouch, J. D. Roby, B. Starcher, and R. A. Pierce, “Increased elastin production in experimental granulomatous lung disease,” The American Journal of Pathology, vol. 147, no. 4, pp. 988–1000, 1995. View at Google Scholar · View at Scopus
  50. J. Pérez-Ramos, M. D. L. Segura-Valdez, B. Vanda, M. Selman, and A. Pardo, “Matrix metalloproteinases 2, 9, and 13, and tissue inhibitors of metalloproteinases 1 and 2 in experimental lung silicosis,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 4, pp. 1274–1282, 1999. View at Publisher · View at Google Scholar · View at Scopus
  51. J. F. Scabilloni, L. Wang, J. M. Antonini, J. R. Roberts, V. Castranova, and R. R. Mercer, “Matrix metalloproteinase induction in fibrosis and fibrotic nodule formation due to silica inhalation,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 288, no. 4, pp. L709–L717, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. S.-Q. Yao, L. W. Rojanasakul, Z.-Y. Chen et al., “Fas/FasL pathway-mediated alveolar macrophage apoptosis involved in human silicosis,” Apoptosis, vol. 16, no. 12, pp. 1195–1204, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. W. W. Liu, H. X. Wang, W. Yu et al., “Treatment of silicosis with hepatocyte growth factor-modified autologous bone marrow stromal cells: a non-randomized study with follow-up,” Genetics and Molecular Research, vol. 14, no. 3, pp. 10672–10681, 2015. View at Publisher · View at Google Scholar
  54. M. M. Morales, S. A. Souza, L. P. Loivos et al., “Pilot safety study of intrabronchial instillation of bone marrow-derived mononuclear cells in patients with silicosis,” BMC Pulmonary Medicine, vol. 15, article 66, 2015. View at Publisher · View at Google Scholar
  55. S. K. Sharma, J. N. Pande, and K. Verma, “Effect of prednisolone treatment in chronic silicosis,” American Review of Respiratory Disease, vol. 143, no. 4, pp. 814–821, 1991. View at Publisher · View at Google Scholar · View at Scopus
  56. G. B. Goodman, P. D. Kaplan, I. Stachura, V. Castranova, W. H. Pailes, and N. L. Lapp, “Acute silicosis responding to corticosteroid therapy,” Chest, vol. 101, no. 2, pp. 366–370, 1992. View at Publisher · View at Google Scholar · View at Scopus
  57. F. Dubois, R. Bégin, A. Cantin et al., “Aluminum inhalation reduces silicosis in a sheep model,” American Review of Respiratory Disease, vol. 137, no. 5, pp. 1172–1179, 1988. View at Publisher · View at Google Scholar · View at Scopus
  58. E. Mccartney, “Aluminium therapy of silicosis,” British Medical Journal, vol. 1, pp. 839–840, 1946. View at Google Scholar
  59. M. C. Kennedy, “Aluminium powder inhalations in the treatment of silicosis of pottery workers and pneumoconiosis of coal-miners,” British Journal of Industrial Medicine, vol. 13, no. 2, pp. 85–101, 1956. View at Google Scholar · View at Scopus
  60. H. W. Schlipköter, “Possibilities of causal prophylaxis and therapy of pneumoconiosis,” Archives of Environmental Health, vol. 21, no. 2, pp. 181–191, 1970. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Zhao, J. Liu, and G. Li, “Long-term follow-up observations of the therapeutic effect of PVNO on human silicosis,” Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene Serie B, vol. 178, pp. 259–262, 1983. View at Google Scholar
  62. I. Idec-Sadkowska, R. Andrzejak, J. Antonowicz-Juchniewicz, and B. Kaczmarek-Wdowiak, “Trials of casual treatment of silicosis,” Medycyna Pracy, vol. 57, no. 3, pp. 271–280, 2006. View at Google Scholar · View at Scopus
  63. Q.-M. Xie, H.-F. Tang, J.-Q. Chen, and R.-L. Bian, “Pharmacological actions of tetrandrine in inflammatory pulmonary diseases,” Acta Pharmacologica Sinica, vol. 23, no. 12, pp. 1107–1113, 2002. View at Google Scholar · View at Scopus
  64. J. Guo, N. Gu, J. Chen et al., “Neutralization of interleukin-1 beta attenuates silica-induced lung inflammation and fibrosis in C57BL/6 mice,” Archives of Toxicology, vol. 87, no. 11, pp. 1963–1973, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Guo, T. Shi, X. Cui et al., “Effects of silica exposure on the cardiac and renal inflammatory and fibrotic response and the antagonistic role of interleukin-1 β in C57BL/6 mice,” Archives of Toxicology, vol. 90, no. 2, pp. 247–258, 2016. View at Publisher · View at Google Scholar · View at Scopus
  66. P. F. Piguet, C. Vesin, G. E. Grau, and R. C. Thompson, “Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica,” Cytokine, vol. 5, no. 1, pp. 57–61, 1993. View at Publisher · View at Google Scholar · View at Scopus
  67. G. Cavalli, F. Fallanca, C. A. Dinarello, and L. Dagna, “Treating pulmonary silicosis by blocking Interleukin 1,” American Journal of Respiratory and Critical Care Medicine, vol. 191, no. 5, pp. 596–598, 2015. View at Publisher · View at Google Scholar
  68. M. Stafford, A. Cappa, M. Weyant et al., “Treatment of acute silicoproteinosis by whole-lung lavage,” Seminars in Cardiothoracic and Vascular Anesthesia, vol. 17, no. 2, pp. 152–159, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. G. R. Mason, J. L. Abraham, L. Hoffman, S. Cole, M. Lippmann, and K. Wasserman, “Treatment of mixed-dust pneumoconiosis with whole lung lavage,” American Review of Respiratory Disease, vol. 126, no. 6, pp. 1102–1107, 1982. View at Google Scholar · View at Scopus
  70. M. R. Schuyler, H. R. Gaumer, R. P. Stankus, J. Kaimal, E. Hoffmann, and J. E. Salvaggio, “Bronchoalveolar lavage in silicosis: evidence of type II cell hyperplasia,” Lung, vol. 157, no. 1, pp. 95–102, 1979. View at Publisher · View at Google Scholar
  71. Y. Chen, J. Chen, J. Dong, and W. Liu, “Antifibrotic effect of interferon gamma in silicosis model of rat,” Toxicology Letters, vol. 155, no. 3, pp. 353–360, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. J. L. Kaw and S. H. Zaidi, “Effect of ascorbic acid on pulmonary silicosis of guinea pigs,” Archives of Environmental Health, vol. 19, no. 1, pp. 74–82, 1969. View at Publisher · View at Google Scholar
  73. C. I. Levene, I. Bye, and U. Saffiotti, “The effect of beta-aminopropionitrile on silicotic pulmonary fibrosis in the rat,” British Journal of Experimental Pathology, vol. 49, no. 2, pp. 152–159, 1968. View at Google Scholar · View at Scopus
  74. X.-F. Li, J. Liao, Z.-Q. Xin, W.-Q. Lu, and A.-L. Liu, “Relaxin attenuates silica-induced pulmonary fibrosis by regulating collagen type I and MMP-2,” International Immunopharmacology, vol. 17, no. 3, pp. 537–542, 2013. View at Publisher · View at Google Scholar
  75. T. Sato, T. Shimosato, W. G. Alvord, and D. M. Klinman, “Suppressive oligodeoxynucleotides inhibit silica-induced pulmonary inflammation,” Journal of Immunology, vol. 180, no. 11, pp. 7648–7654, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. M. H. Sharawy, D. S. El-Agamy, A. A. Shalaby, and E.-S. M. Ammar, “Protective effects of methyl palmitate against silica-induced pulmonary fibrosis in rats,” International Immunopharmacology, vol. 16, no. 2, pp. 191–198, 2013. View at Publisher · View at Google Scholar · View at Scopus
  77. L. Zhang, Y. He, Q. Li et al., “N-acetylcysteine alleviated silica-induced lung fibrosis in rats by down-regulation of ROS and mitochondrial apoptosis signaling,” Toxicology Mechanisms and Methods, vol. 24, no. 3, pp. 212–219, 2013. View at Publisher · View at Google Scholar
  78. F. F. Cruz, L. F. B. Horta, L. D. A. Maia et al., “Dasatinib reduces lung inflammation and fibrosis in acute experimental silicosis,” PLoS ONE, vol. 11, no. 1, Article ID e0147005, 2016. View at Publisher · View at Google Scholar
  79. L. Wollin, I. Maillet, V. Quesniaux, A. Holweg, and B. Ryffel, “Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis,” The Journal of Pharmacology and Experimental Therapeutics, vol. 349, no. 2, pp. 209–220, 2014. View at Publisher · View at Google Scholar
  80. T. P. T. Ferreira, A. C. S. De Arantes, C. V. M. F. Do Nascimento et al., “IL-13 immunotoxin accelerates resolution of lung pathological changes triggered by silica particles in mice,” Journal of Immunology, vol. 191, no. 10, pp. 5220–5229, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. Y. Chen, C. Li, D. Weng et al., “Neutralization of interleukin-17A delays progression of silica-induced lung inflammation and fibrosis in C57BL/6 mice,” Toxicology and Applied Pharmacology, vol. 275, no. 1, pp. 62–72, 2014. View at Publisher · View at Google Scholar · View at Scopus
  82. X. Ji, B. Wu, J. Fan et al., “The anti-fibrotic effects and mechanisms of microRNA-486-5p in pulmonary fibrosis,” Scientific Reports, vol. 5, Article ID 14131, 2015. View at Publisher · View at Google Scholar
  83. X. Wang, W. Dai, Y. Wang, Q. Gu, D. Yang, and M. Zhang, “Blocking the Wnt/β-catenin pathway by lentivirus-mediated short hairpin RNA targeting β-catenin gene suppresses silica-induced lung fibrosis in mice,” International Journal of Environmental Research and Public Health, vol. 12, no. 9, pp. 10739–10754, 2015. View at Publisher · View at Google Scholar
  84. M. Hartert, O. Senbaklavacin, B. Gohrbandt, B. M. Fischer, R. Buhl, and C.-F. Vahld, “Lung transplantation: a treatment option in end-stage lung disease,” Deutsches Ärzteblatt International, vol. 111, no. 7, pp. 107–116, 2014. View at Publisher · View at Google Scholar
  85. E. D. Thomas, J. H. Phillips, and C. A. Finch, “Recovery from marrow failure following isogenic marrow infusion,” The Journal of the American Medical Association, vol. 188, pp. 1041–1043, 1964. View at Google Scholar · View at Scopus
  86. M. J. Evans and M. H. Kaufman, “Establishment in culture of pluripotential cells from mouse embryos,” Nature, vol. 292, no. 5819, pp. 154–156, 1981. View at Publisher · View at Google Scholar · View at Scopus
  87. L. da Silva Meirelles, P. C. Chagastelles, and N. B. Nardi, “Mesenchymal stem cells reside in virtually all post-natal organs and tissues,” Journal of Cell Science, vol. 119, no. 11, pp. 2204–2213, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. L. da Silva Meirelles, A. M. Fontes, D. T. Covas, and A. I. Caplan, “Mechanisms involved in the therapeutic properties of mesenchymal stem cells,” Cytokine and Growth Factor Reviews, vol. 20, no. 5-6, pp. 419–427, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. D. S. Krause, “Bone marrow-derived cells and stem cells in lung repair,” Proceedings of the American Thoracic Society, vol. 5, no. 3, pp. 323–327, 2008. View at Publisher · View at Google Scholar
  90. M. Z. Ratajczak, “Phenotypic and functional characterization of hematopoietic stem cells,” Current Opinion in Hematology, vol. 15, no. 4, pp. 293–300, 2008. View at Publisher · View at Google Scholar
  91. A. I. Caplan, “Mesenchymal stem cells,” Journal of Orthopaedic Research, vol. 9, no. 5, pp. 641–650, 1991. View at Publisher · View at Google Scholar
  92. S. C. Abreu, M. A. Antunes, J. C. de Castro et al., “Bone marrow-derived mononuclear cells vs. Mesenchymal stromal cells in experimental allergic asthma,” Respiratory Physiology and Neurobiology, vol. 187, no. 2, pp. 190–198, 2013. View at Publisher · View at Google Scholar · View at Scopus
  93. F. F. Cruz, Z. D. Borg, M. Goodwin et al., “Systemic administration of human bone marrow-derived mesenchymal stromal cell extracellular vesicles ameliorates aspergillus hyphal extract-induced allergic airway inflammation in immunocompetent mice,” Stem Cells Translational Medicine, vol. 4, no. 11, pp. 1302–1316, 2015. View at Publisher · View at Google Scholar
  94. Y. Moodley, D. Atienza, U. Manuelpillai et al., “Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury,” The American Journal of Pathology, vol. 175, no. 1, pp. 303–313, 2009. View at Publisher · View at Google Scholar · View at Scopus
  95. D. J. Weiss, “Concise review: current status of stem cells and regenerative medicine in lung biology and diseases,” Stem Cells, vol. 32, no. 1, pp. 16–25, 2014. View at Publisher · View at Google Scholar · View at Scopus
  96. R. M. R. Lassance, L. F. M. Prota, T. Maron-Gutierrez et al., “Intratracheal instillation of bone marrow-derived cell in an experimental model of silicosis,” Respiratory Physiology & Neurobiology, vol. 169, no. 3, pp. 227–233, 2009. View at Publisher · View at Google Scholar
  97. T. Maron-Gutierrez, R. C. Castiglione, D. G. Xisto et al., “Bone marrow-derived mononuclear cell therapy attenuates silica-induced lung fibrosis,” European Respiratory Journal, vol. 37, no. 5, pp. 1217–1225, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. P. Spitalieri, M. C. Quitadamo, A. Orlandi et al., “Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells,” European Respiratory Journal, vol. 39, no. 2, pp. 446–457, 2012. View at Publisher · View at Google Scholar · View at Scopus
  99. M.-M. Zhao, J.-Z. Cui, Y. Cui et al., “Therapeutic effect of exogenous bone marrow-derived mesenchymal stem cell transplantation on silicosis via paracrine mechanisms in rats,” Molecular Medicine Reports, vol. 8, no. 3, pp. 741–746, 2013. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Choi, T. Ban, and T. Rhim, “Therapeutic use of stem cell transplantation for cell replacement or cytoprotective effect of microvesicle released from mesenchymal stem cell,” Molecules and Cells, vol. 37, no. 2, pp. 133–139, 2014. View at Publisher · View at Google Scholar · View at Scopus
  101. S. C. Abreu, M. A. Antunes, L. Mendonça et al., “Effects of bone marrow mononuclear cells from healthy or ovalbumin-induced lung inflammation donors on recipient allergic asthma mice,” Stem Cell Research and Therapy, vol. 5, article 108, 2014. View at Publisher · View at Google Scholar · View at Scopus
  102. E. G. Mannheimer, A. B. Carvalho, L. F. Quintanilha et al., “Bone marrow cells obtained from cirrhotic rats do not improve function or reduce fibrosis in a chronic liver disease model,” Clinical Transplantation, vol. 25, no. 1, pp. 54–60, 2011. View at Publisher · View at Google Scholar · View at Scopus